Mitchell Elliott

@Yale @YaleCancer Assistant Professor. Usually found carrying coffee.

[Princess Margaret Cancer Centre Research @PMResearch_UHN]

Our new study @UHN @pmcancercentre shows that a methylation-based blood test measuring tumour DNA can accurately monitor treatment response & detect signs of treatment failure a median of six months before clinical progression in metastatic breast cancer.
https://t.co/clFTQBLQPa

[ASCO @ASCO]

🎙️@hoperugo of @UCSFCancer, Dr. Diana Lam of @FredHutch, @SherryShenMD of @MSKCancerCenter & @MitchElliott18 of @pmcancercentre highlight key strategies for early-stage #BreastCancer survivorship on the #ASCODailyNews Podcast: https://t.co/pbuWKek6qK #bcsm

[Mitchell Elliott @MitchElliott18]

@OncoAlert @oncodaily

[Mitchell Elliott @MitchElliott18]

Truly an honour to join this amazing group of #NOYCIA award recipients this year. Looking forward to sharing our data RE: ctDNA monitoring in ER+/HER2- metastatic #breastcancer to improve patient outcomes and #QoL

@pmcancercentre @PMResearch_UHN

[Novartis Canada @NovartisCanada]

Congratulations to the 2024 Novartis Oncology Young Canadian Investigator Award recipients!

A Canadian contingent of more than 90 attended the #NOYCIAAwards at #ASCO2024 to see our 10 #NOYCIA recipients present their winning research, showcasing Canada’s significant contribution to #oncology.

Visit https://t.co/YQuTpzeQAp for more information.

[Mitchell Elliott @MitchElliott18]

Thank you @JCOPO_ASCO for a fantastic year as an #EditorialFellow. Looking forward to being a fellowship mentor this year!

@ASCO #ASCO24

[Lillian Siu @lillian_siu]

Honoured to pose with @ASCO CEO at the end of the opening plenary and with the 🍁 crowd from @pmcancercentre and friends

[Sharlene Gill, MD, MPH, MBA, FASCO @GillSharlene]

Shout-out to our 🇨🇦 cancer rock star, @lillian_siu - the recipient of @ASCO #ASCO24 David Karnofsky Award🥇
A well-deserved recognition for her remarkable scientific contribution & for mentoring a generation of ⭐️ clinician-scientists 👏 🌎
Congratulations Lillian!
@CDNCancerTrials @pmcancercentre

[Laila Agrawal, MD @LailaAgrawalMD]

Weight , alcohol, and exercise on breast cancer recurrence risk @Neil_Iyengar

🏃‍♀️Growing evidence on the benefit of exercise
🍷Any amount of alcohol can increase risk
🥦Plant based, high fiber, avoid 🥩

[Erika Hamilton, MD, FASCO @ErikaHamilton9]

@Neil_Iyengar - lifestyle modification as a tool for modifying risk of #bcsm recurrence

🔸Obesity linked with 13 cancers

🔹Weight gain after #bcsm diagnosis associated with increase mortality (partially above 10%)

🔺exercise quite important in risk reduction (40%)

#ASCO24

[Neil Iyengar, MD @Neil_Iyengar]

Kicking off the session with an important talk from @tperrybrown. “Survivorship begins at diagnosis” - this is the model we pursue in the MSK Healthy Living Program!

https://t.co/Ffv8Pb1a1g

[Mitchell Elliott @MitchElliott18]

@jjonestoronto @SherryShenMD @Neil_Iyengar @UWBreastImaging @tperrybrown @ASCO @pmcancercentre Couldn’t agree more! We need better integration of these services for all patients.

[Mitchell Elliott @MitchElliott18]

Excited to share our ASCO Educational Book chapter on Enhancing Early-Stage Breast Cancer Survivorship just in time for #ASCO24. @SherryShenMD @Neil_Iyengar @UWBreastImaging @tperrybrown #DaveCescon

Thank you @ASCO for the opportunity! @pmcancercentre

https://t.co/sYCa9y4PqT

[Neil Iyengar, MD @Neil_Iyengar]

This was a great collaborative effort! Don’t miss our educational session tomorrow at 8am!
Thanks to co-authors including amazing advocate @tperrybrown, @hoperugo , @ASCO education committee.

@MSKCancerCenter #ASCO24

[VJ Oncology @VJOncology]

It was great to speak with @MitchElliott18 of @UofT_DoM at #AACR24, where he discusses his research on tumor-agnostic ctDNA monitoring and novel targets in #breastcancer

🚨 More coming soon on https://t.co/ys1d8pDAKO

@AACR #oncology #bcsm

[Mitchell Elliott @MitchElliott18]

@LisaPorter2 @CAMO_ACOM @PMResearch_UHN @pmcancercentre @L_Porterlabrats Thank you, Lisa!

[Mitchell Elliott @MitchElliott18]

Thank you @CAMO_ACOM for the opportunity to continue my research and improve the care of patients with triple negative breast cancer.

@PMResearch_UHN @pmcancercentre

[Canadian Association of Medical Oncologists @CAMO_ACOM]

Congratulations👏Dr. Mitchell Elliott 2024 K. Jill Rigby fellowship recipient for his project Defining genomic determinants of drug sensitivity and acquired resistance in triple negative breast cancer. Supervising Inst. Princess Margaret Cancer Centre, Toronto ON @MitchElliott18

[Mitchell Elliott @MitchElliott18]

@JerzakKasia @CAMO_ACOM Thank you!

[JCO Precision Oncology @JCOPO_ASCO]

Welcome to our new #JCOPO Editorial Fellows! Drs. @MitchElliott18, Miki Horiguchi & @ferguskeane2 will spend the next year getting a peek behind the curtain of JCO PO and learning from Drs. James Ford, Ying Lu, Bryan Schneider, and others on what it's like to be a journal editor!

[Mitchell Elliott @MitchElliott18]

@z_veitch @PTarantinoMD Excellent presentation today! Will be nice to see the data for treatment free interval for the ~30% of patients with recurrent disease and prior taxane exposure (to be reported in the manuscript).

[Mitchell Elliott @MitchElliott18]

@GitauMahiri @jonahhimelfarb You slept on TGH CCU call?